KaloBios Pharmaceuticals CEO Cameron Durrant's 2021 pay jumps 299% to $9.7M
KaloBios Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 12, 2022
KaloBios Pharmaceuticals reported fiscal year 2021 executive compensation information on April 12, 2022.
In 2021, three executives at KaloBios Pharmaceuticals received on average a compensation package of $4.3M, a 165% increase compared to previous year.
Average pay of disclosed executives at KaloBios Pharmaceuticals
Cameron Durrant, Chief Executive Officer, received $9.7M in total, which increased by 299% compared to 2020. 91% of Durrant's compensation, or $8.9M, was in option awards. Durrant also received $203K in non-equity incentive plan and $640K in salary.
Adrian Kilcoyne, Chief Medical Officer, received a compensation package of $2.4M. 84% of the compensation package, or $2M, was in option awards.
Timothy Morris, Chief Operating and Financial Officer, earned $777K in 2021, a 47% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 12, 2022.